Skip to main content
Erschienen in: Pediatric Cardiology 7/2015

01.10.2015 | Original Article

Maternal Hypertension During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Meta-analysis

verfasst von: Anushuya Ramakrishnan, Laura J. Lee, Laura E. Mitchell, A. J. Agopian

Erschienen in: Pediatric Cardiology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Maternal hypertension is common during pregnancy, and multiple studies have reported on an association between maternal hypertension and congenital heart defects (CHDs) in offspring; however, there is variability in the quality of these studies. A systematic review and meta-analysis was conducted on the associations between untreated and treated maternal hypertension and the risk of CHDs, evaluating CHDs overall as well as specific CHD subtypes. A systematic search of peer-reviewed articles published before August 2013 identified 16 studies evaluating the associations between untreated and treated maternal hypertension and CHDs. Summary relative risk (RR) estimates were calculated using fixed-effects models and random-effects models. Significant associations were observed between maternal hypertension and overall CHDs, for both treated [RR 2.0; 95 % confidence interval (CI) 1.5, 2.7] and untreated (RR 1.4; 95 % CI 1.2, 1.7) hypertension, as well as for overall hypertension regardless of treatment status (RR 1.8; 95 % CI 1.5, 2.2). The magnitude of effect was similar for the majority of CHD subtypes evaluated. The effects were also similar among women with hypertension who used one of multiple specific hypertension medications. There was no evidence of publication bias, and our results were robust to several factors considered in sensitivity analyses (e.g., source of exposure data, adjustment for potential confounders, and study design). Maternal hypertension was associated with CHDs. By understanding the specific mechanisms involved, appropriate strategies may be developed to reduce this risk, in order to prevent CHDs.
Literatur
3.
Zurück zum Zitat Ananth CV, Peedicayil A, Savitz DA (1995) Effect of hypertensive diseases in pregnancy on birthweight, gestational duration, and small-for-gestational-age births. Epidemiology 6(4):391–395CrossRefPubMed Ananth CV, Peedicayil A, Savitz DA (1995) Effect of hypertensive diseases in pregnancy on birthweight, gestational duration, and small-for-gestational-age births. Epidemiology 6(4):391–395CrossRefPubMed
4.
Zurück zum Zitat Banhidy F, Acs N, Puho EH, Czeizel AE (2011) Chronic hypertension with related drug treatment of pregnant women and congenital abnormalities in their offspring: a population-based study. Hypertens Res 34(2):257–263. doi:10.1038/hr.2010.227 CrossRefPubMed Banhidy F, Acs N, Puho EH, Czeizel AE (2011) Chronic hypertension with related drug treatment of pregnant women and congenital abnormalities in their offspring: a population-based study. Hypertens Res 34(2):257–263. doi:10.​1038/​hr.​2010.​227 CrossRefPubMed
5.
Zurück zum Zitat Bateman BT, Huybrechts KF, Fischer MA, Seely EW, Ecker JL, Oberg AS, Franklin JM, Mogun H, Hernandez-Diaz S (2014) Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study. Am J Obstet Gynecol. doi:10.1016/j.ajog.2014.09.031 PubMedCentral Bateman BT, Huybrechts KF, Fischer MA, Seely EW, Ecker JL, Oberg AS, Franklin JM, Mogun H, Hernandez-Diaz S (2014) Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study. Am J Obstet Gynecol. doi:10.​1016/​j.​ajog.​2014.​09.​031 PubMedCentral
6.
Zurück zum Zitat Botto LD, Correa A, Erickson JD (2001) Racial and temporal variations in the prevalence of heart defects. Pediatrics 107(3):E32CrossRefPubMed Botto LD, Correa A, Erickson JD (2001) Racial and temporal variations in the prevalence of heart defects. Pediatrics 107(3):E32CrossRefPubMed
7.
Zurück zum Zitat Botto LD, Lin AE, Riehle-Colarusso T, Malik S, National Birth Defects Prevention Study (2007) Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A 79(10):714–727. doi:10.1002/bdra.20403 CrossRef Botto LD, Lin AE, Riehle-Colarusso T, Malik S, National Birth Defects Prevention Study (2007) Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A 79(10):714–727. doi:10.​1002/​bdra.​20403 CrossRef
8.
Zurück zum Zitat Caton AR, Bell EM, Druschel CM, Werler MM, Lin AE, Browne ML, McNutt LA, Romitti PA, Mitchell AA, Olney RS, Correa A, National Birth Defects Prevention Study (2009) Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension 54(1):63–70. doi:10.1161/HYPERTENSIONAHA.109.129098 CrossRefPubMed Caton AR, Bell EM, Druschel CM, Werler MM, Lin AE, Browne ML, McNutt LA, Romitti PA, Mitchell AA, Olney RS, Correa A, National Birth Defects Prevention Study (2009) Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension 54(1):63–70. doi:10.​1161/​HYPERTENSIONAHA.​109.​129098 CrossRefPubMed
9.
Zurück zum Zitat CDC (1997) Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy—United States, Canada and Isreal, 1987–1995. MMWR Morb Mortal Wkly Rep 46:2 CDC (1997) Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy—United States, Canada and Isreal, 1987–1995. MMWR Morb Mortal Wkly Rep 46:2
10.
Zurück zum Zitat Clark EB (1986) Mechanisms in the pathogenesis of congenital cardiac malformations. In: Pierpont ME, Moller JH (eds) The genetics of cardiovascular disease. Martinus Nijhoff Publishing, Boston, MA, p 8 Clark EB (1986) Mechanisms in the pathogenesis of congenital cardiac malformations. In: Pierpont ME, Moller JH (eds) The genetics of cardiovascular disease. Martinus Nijhoff Publishing, Boston, MA, p 8
11.
Zurück zum Zitat Clark EB (1996) Pathogenetic mechanisms of congenital cardiovascular malformations revisited. Semin Perinatol 20(6):465–472CrossRefPubMed Clark EB (1996) Pathogenetic mechanisms of congenital cardiovascular malformations revisited. Semin Perinatol 20(6):465–472CrossRefPubMed
12.
Zurück zum Zitat Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354(23):2443–2451. doi:10.1056/NEJMoa055202 CrossRefPubMed Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354(23):2443–2451. doi:10.​1056/​NEJMoa055202 CrossRefPubMed
14.
Zurück zum Zitat Davis RL, Eastman D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Dublin S, Platt R (2011) Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf 20(2):138–145. doi:10.1002/pds.2068 PubMedCentralCrossRefPubMed Davis RL, Eastman D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Dublin S, Platt R (2011) Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf 20(2):138–145. doi:10.​1002/​pds.​2068 PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed
16.
Zurück zum Zitat Excellence NIfHaC (2010) Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. NICE Guidelines. Accessed June 9, 2014 Excellence NIfHaC (2010) Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. NICE Guidelines. Accessed June 9, 2014
17.
Zurück zum Zitat Fang J, Madhavan S, Alderman MH (1999) The influence of maternal hypertension on low birth weight: differences among ethnic populations. Ethn Dis 9(3):369–376PubMed Fang J, Madhavan S, Alderman MH (1999) The influence of maternal hypertension on low birth weight: differences among ethnic populations. Ethn Dis 9(3):369–376PubMed
18.
Zurück zum Zitat Ferencz C, Rubin J, Loffredo C, Magee C (1993) Epidemiology of Congenital Heart Disease: the Baltimore Washington Infant Study 1981–89. Futura Publishing Company, Mount Kisco Ferencz C, Rubin J, Loffredo C, Magee C (1993) Epidemiology of Congenital Heart Disease: the Baltimore Washington Infant Study 1981–89. Futura Publishing Company, Mount Kisco
19.
Zurück zum Zitat Hoffman JI (1990) Congenital heart disease: incidence and inheritance. Pediatr Clin North Am 37(1):25–43PubMed Hoffman JI (1990) Congenital heart disease: incidence and inheritance. Pediatr Clin North Am 37(1):25–43PubMed
20.
Zurück zum Zitat Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, Elixson M, Warnes CA, Webb CL, American Heart Association Council on Cardiovascular Disease in the Young (2007) Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115(23):2995–3014. doi:10.1161/CIRCULATIONAHA.106.183216 CrossRefPubMed Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, Elixson M, Warnes CA, Webb CL, American Heart Association Council on Cardiovascular Disease in the Young (2007) Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115(23):2995–3014. doi:10.​1161/​CIRCULATIONAHA.​106.​183216 CrossRefPubMed
21.
Zurück zum Zitat Johnson KC, Rouleau J (1997) Temporal trends in Canadian birth defects birth prevalences, 1979–1993. Can J Public Health 88(3):169–176PubMed Johnson KC, Rouleau J (1997) Temporal trends in Canadian birth defects birth prevalences, 1979–1993. Can J Public Health 88(3):169–176PubMed
22.
Zurück zum Zitat Kallen BA, Otterblad Olausson P (2003) Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17(3):255–261CrossRefPubMed Kallen BA, Otterblad Olausson P (2003) Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17(3):255–261CrossRefPubMed
24.
Zurück zum Zitat Lennestal R, Otterblad Olausson P, Kallen B (2009) Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 65(6):615–625. doi:10.1007/s00228-009-0620-0 CrossRefPubMed Lennestal R, Otterblad Olausson P, Kallen B (2009) Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 65(6):615–625. doi:10.​1007/​s00228-009-0620-0 CrossRefPubMed
25.
Zurück zum Zitat Lennestal R, Olausson P, Kallen B (2009) Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in infants. Eur J Clin Phamacol 65:10CrossRef Lennestal R, Olausson P, Kallen B (2009) Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in infants. Eur J Clin Phamacol 65:10CrossRef
26.
28.
Zurück zum Zitat Malm H, Artama M, Gissler M, Klaukka T, Merilainen J, Nylander O, Padlan M, Palva E, Ritvannen A, Tyrkko K (2008) First trimester use of ACE-inhibitors and risk of major malformations. Reprod Toxicol 05:5 Malm H, Artama M, Gissler M, Klaukka T, Merilainen J, Nylander O, Padlan M, Palva E, Ritvannen A, Tyrkko K (2008) First trimester use of ACE-inhibitors and risk of major malformations. Reprod Toxicol 05:5
29.
Zurück zum Zitat Mastrobattista JM (1997) Angiotensin converting enzyme inhibitors in pregnancy. Semin Perinatol 21(2):124–134CrossRefPubMed Mastrobattista JM (1997) Angiotensin converting enzyme inhibitors in pregnancy. Semin Perinatol 21(2):124–134CrossRefPubMed
32.
Zurück zum Zitat Nakhai-Pour HR, Rey E, Berard A (2010) Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns. Birth Defects Res B 89(2):147–154. doi:10.1002/bdrb.20238 Nakhai-Pour HR, Rey E, Berard A (2010) Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns. Birth Defects Res B 89(2):147–154. doi:10.​1002/​bdrb.​20238
34.
Zurück zum Zitat Roberts JMAP, Bakris G et al (2013) Hypertension in pregnancy report of the American College of Obstetricians and Gynecologists’ Task Force on hypertension in pregnancy. Obstet Gynecol 122(5):9 Roberts JMAP, Bakris G et al (2013) Hypertension in pregnancy report of the American College of Obstetricians and Gynecologists’ Task Force on hypertension in pregnancy. Obstet Gynecol 122(5):9
35.
Zurück zum Zitat Schoendorfer C, Hannemann D, Meister R, Eléfant E, Maarschalkerweerd B, Arnon J, Vial T, Pinilla E, Clementi M, Gnansia E, Santis M, MalmH Dolivo A, Schaefer C (2008) The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol 26:24CrossRef Schoendorfer C, Hannemann D, Meister R, Eléfant E, Maarschalkerweerd B, Arnon J, Vial T, Pinilla E, Clementi M, Gnansia E, Santis M, MalmH Dolivo A, Schaefer C (2008) The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol 26:24CrossRef
36.
Zurück zum Zitat Sorensen HT, Czeizel AE, Rockenbauer M, Steffensen FH, Olsen J (2001) The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers. Acta Obstet Gynecol Scand 80(5):397–401CrossRefPubMed Sorensen HT, Czeizel AE, Rockenbauer M, Steffensen FH, Olsen J (2001) The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers. Acta Obstet Gynecol Scand 80(5):397–401CrossRefPubMed
37.
Zurück zum Zitat Tikkanen J, Heinonen OP (1990) Risk factors for cardiovascular malformations in Finland. Eur J Epidemiol 6(4):348–356CrossRefPubMed Tikkanen J, Heinonen OP (1990) Risk factors for cardiovascular malformations in Finland. Eur J Epidemiol 6(4):348–356CrossRefPubMed
39.
Zurück zum Zitat Vereczkey A, Kosa Z, Csaky-Szunyogh M, Gerencser B, Czeizel AE (2014) Birth outcomes of cases with conotruncal defects of heart—a population-based case–control study. J Maternal-Fetal Neonatal Med. doi:10.3109/14767058.2014.918598 Vereczkey A, Kosa Z, Csaky-Szunyogh M, Gerencser B, Czeizel AE (2014) Birth outcomes of cases with conotruncal defects of heart—a population-based case–control study. J Maternal-Fetal Neonatal Med. doi:10.​3109/​14767058.​2014.​918598
40.
Zurück zum Zitat Yang Q, Chen H, Correa A, Devine O, Mathews TJ, Honein MA (2006) Racial differences in infant mortality attributable to birth defects in the United States, 1989–2002. Birth Defects Res A 76(10):706–713. doi:10.1002/bdra.20308 CrossRef Yang Q, Chen H, Correa A, Devine O, Mathews TJ, Honein MA (2006) Racial differences in infant mortality attributable to birth defects in the United States, 1989–2002. Birth Defects Res A 76(10):706–713. doi:10.​1002/​bdra.​20308 CrossRef
Metadaten
Titel
Maternal Hypertension During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Meta-analysis
verfasst von
Anushuya Ramakrishnan
Laura J. Lee
Laura E. Mitchell
A. J. Agopian
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 7/2015
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-015-1182-9

Weitere Artikel der Ausgabe 7/2015

Pediatric Cardiology 7/2015 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.